Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bicycle Therapeutics (BCYC) Cash from Investing Activities: 2018-2025

Historic Cash from Investing Activities for Bicycle Therapeutics (BCYC) over the last 7 years, with Sep 2025 value amounting to -$674,000.

  • Bicycle Therapeutics' Cash from Investing Activities fell 54.94% to -$674,000 in Q3 2025 from the same period last year, while for Sep 2025 it was -$2.1 million, marking a year-over-year decrease of 133.55%. This contributed to the annual value of -$1.2 million for FY2024, which is 57.84% up from last year.
  • Bicycle Therapeutics' Cash from Investing Activities amounted to -$674,000 in Q3 2025, which was down 35.34% from -$498,000 recorded in Q2 2025.
  • Bicycle Therapeutics' Cash from Investing Activities' 5-year high stood at -$12,000 during Q1 2024, with a 5-year trough of -$9.8 million in Q2 2022.
  • In the last 3 years, Bicycle Therapeutics' Cash from Investing Activities had a median value of -$435,000 in 2024 and averaged -$540,000.
  • Its Cash from Investing Activities has fluctuated over the past 5 years, first slumped by 5,630.41% in 2022, then surged by 99.43% in 2024.
  • Quarterly analysis of 5 years shows Bicycle Therapeutics' Cash from Investing Activities stood at -$1.1 million in 2021, then slumped by 35.71% to -$1.4 million in 2022, then soared by 96.48% to -$51,000 in 2023, then crashed by 621.57% to -$368,000 in 2024, then plummeted by 54.94% to -$674,000 in 2025.
  • Its Cash from Investing Activities stands at -$674,000 for Q3 2025, versus -$498,000 for Q2 2025 and -$604,000 for Q1 2025.